Bolivia vs Gambia: Cause of death, by non-communicable diseases, female
Bolivia
41.7%
in 2021
Gambia
42.5%
in 2021
Bolivia rank
156th
Gambia rank
153rd
Cause of death, by non-communicable diseases, female over time
- Bolivia
- Gambia
How they compare
Gambia currently reports 42.5% against 41.7% in Bolivia, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Bolivia ahead.
Bolivia ranks 156th and Gambia ranks 153rd of 185 countries.
Bolivia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.0% | 28.5% | 27.5% | Bolivia |
| 2010s | 69.6% | 38.6% | 30.9% | Bolivia |
| 2020s | 43.5% | 43.0% | 0.5% | Bolivia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Bolivia or Gambia?
- Gambia, at 42.5% against 41.7% in Bolivia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Bolivia and Gambia?
- 0.8%, with Gambia ahead.
- How many years of comparable data are there for Bolivia and Gambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Bolivia and Gambia rank globally for cause of death, by non-communicable diseases, female?
- Bolivia ranks 156th and Gambia ranks 153rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.